SPOTLIGHT -
Achieving Durable Clinical Response with Targeted Treatment for Vitiligo
In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.
Read More
Achieving Durable Clinical Response with Targeted Treatments for Vitiligo
Novel Systemic and Topical Treatment for Plaque Psoriasis
In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis
Novel Systemic and Topical Treatments for Plaque Psoriasis
In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis.
AD Clinical Approach: Switching Therapies
Christopher G. Bunick, MD, PhD, shares their clinical approach for switching therapies for atopic dermatitis (AD) treatment.
RAD 2023 AD Trial: Meta-Analysis Data
A dermatology expert provides an overview of the results of the meta-analysis data from the RAD 2023 atopic dermatitis (AD) trial.
AD: Efficacy Outcomes
Christopher G. Bunick, MD, PhD, discusses underutilized efficacy outcomes in atopic dermatitis (AD) clinical trials.
NRS in AD Treatment
A dermatology expert discusses how numerical rating scale (NRS) is used in atopic dermatitis (AD) clinical trials.
EASI Scores in AD Treatment
A dermatology expert discusses how the standard of care EASI scores have been improving with newer atopic dermatitis (AD) therapies.
Clinical Outcomes in AD Clinical Trials
Christopher G. Bunick, MD, PhD, provides an overview of clinical trial outcomes in atopic dermatitis (AD).
Standard of Care in AD
Christopher G. Bunick, MD, PhD, discusses what can be done to improve the standard of care for atopic dermatitis (AD).
